Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Evaluation of Intravenously Administered Tirapazamine Plus Cisplatin in Cervical Cancer.

Trial Profile

Evaluation of Intravenously Administered Tirapazamine Plus Cisplatin in Cervical Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Jun 2012

At a glance

  • Drugs Tirapazamine (Primary) ; Cisplatin
  • Indications Cervical cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Nov 2007 New trial centres added.
    • 08 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top